Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Xingmei Duan,1,2,* Minjie Mu,3,* Junfeng Yan,1 Lan Bai,1 Lei Zhong,1 Yuxuan Zhu,1 Haixia Pan,1 Mei Zhang,3 Jianyou Shi1,3 1Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People`s Hospital, Chengdu, 2State Key Laboratory of Biotherapy and Can...

Full description

Bibliographic Details
Main Authors: Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:International Journal of Nanomedicine
Subjects:
RNA interference
Aurora-A kinase inhibitor
liposome
co-delivery
melanoma
apoptosis.
Online Access:https://www.dovepress.com/co-delivery-of-aurora-a-inhibitor-xy-4-and-bcl-xl-sirna-enhances-antit-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/co-delivery-of-aurora-a-inhibitor-xy-4-and-bcl-xl-sirna-enhances-antit-peer-reviewed-article-IJN

Similar Items